Le Lézard
Classified in: Business
Subjects: ERN, CCA, ERP, DIV

Safeguard Scientifics Announces Third Quarter 2019 Financial Results and Declares Cash Dividend of $1.00 Per Share


RADNOR, Pa., Nov. 7, 2019 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE: SFE) ("Safeguard" or the "Company") today announced financial results.  For the three months ended September 30, 2019, Safeguard's net loss was $2.5 million, or $0.12 per share on a basic and fully diluted basis, as compared with net income of $32.1 million or $1.56 per share, for the same period in 2018.  For the nine months ended September 30, 2019, Safeguard's net income was $55.3 million, or $2.68 per share on a basic and fully diluted basis, as compared with a net income of $1.0 million or $0.05 per share for the same period in 2018.

On November 7, 2019, the Safeguard Board of Directors declared a special cash dividend of $1.00 per share, payable on December 30, 2019 to shareholders of record as of the close of business on December 23, 2019 (the "Record Date").  The ex-dividend date will be the trading day immediately prior to the Record Date.

"This dividend demonstrates our commitment to return value to our shareholders.  And, we remain committed to continuing to reward our shareholders by maximizing the overall value of our partner company holdings and by returning that value to our shareholders as quickly and tax efficiently as possible," said Brian J. Sisko, Safeguard's President and CEO.  "Since we announced our strategy, we have realized over $184 million in cash proceeds related to monetizations of our partner company interests.  To date we have used those proceeds to continue to support our partner companies; to operate the business; and to retire all of our debt.  We are now able to start returning value to our shareholders.  At this time, our Board of Directors has determined that the most appropriate first step in this stage of the execution of our strategy is to issue a dividend.  We anticipate the dividend to be characterized as a return of capital for Federal tax purposes.  Whenever we have cash and cash equivalents on our balance sheet that exceeds what we believe is prudent to keep on hand to operate the business and continue to support our partner companies, our Board of Directors will authorize share repurchases and/or additional dividends.  Currently, we believe $25 million is the appropriate amount to retain on our balance sheet."

The Company also announced corporate governance changes.  Effective immediately, Board of Director compensation will be paid solely with Safeguard equity.  Also, the size of the Board will be reduced to four from six at the Company's upcoming Annual Meeting.

Highlights

OUTLOOK

Mark A. Herndon, Safeguard's Senior Vice President and Chief Financial Officer, went on to say, "We continue to be encouraged by the performance of our portfolio, and continue to be optimistic about the overall health of our partner companies.  There were no impairments during the quarter.  Excluding our digital media companies, Safeguard's portfolio of partner companies is growing revenue more than 50% in aggregate.  Corporate expenses for the year ended December 31, 2019 are forecasted to be at or below $8.0 million, including incremental accruals for the previously established transaction bonus plan, a substantial decline from 2018.  Follow-on funding requirements for the full year are forecasted to be approximately the same as in 2018.  We expect that follow-on funding requirements will decline significantly in 2020."

U.S. FEDERAL TAX TREATMENT OF THE DIVIDEND

The Company currently believes that, for U.S. federal tax purposes, the cash dividend will be treated as a return of capital to shareholders to the extent of their tax basis in Safeguard's common stock.

The ultimate tax treatment of the dividend will be based on Safeguard's current and accumulated earnings and profits for Safeguard's year ending December 31, 2019.  The process of determining current and accumulated earnings and profits requires a final determination of Safeguard's financial results for the year and a review of certain other factors.  The final determination of the tax treatment of the dividend will be based in part on factors that are outside of the control of Safeguard, including possible transactions involving our remaining partner companies, and which cannot be ascertained at this time.  Accordingly, the expected tax treatment of the dividend is based upon currently available information and is subject to change.  Safeguard expects to update information on the taxation of the dividend following the completion of 2019.

The return of capital dividend as reported on Form 8937 will be available on Safeguard's website.  The Form 8937 will be updated following the determination of Safeguard's financial results for the year ended December 31, 2019 and a review of certain other factors.

The information set forth above is provided only for general use, and does not constitute a complete description of all of the U.S. federal tax consequences of the receipt of the special cash dividend or the ownership and disposition of Safeguard's common stock.  Shareholders should consult their own tax advisors concerning such consequences.

AGGREGATE PARTNER COMPANY REVENUE

Aggregate partner company revenue for Safeguard's 15 remaining partner companies is projected to be between $355 million and $370 million for 2019, lower than previously forecasted.  Aggregate revenue for the same partner companies was $330 million for 2018, which indicates revenue growth between 7% and 12% for the group.  Excluding our digital media companies, the revenue of Safeguard's portfolio of partner companies is growing at more than 50% in aggregate year-over-year.

PARTNER COMPANY HOLDINGS AT SEPTEMBER 30, 2019

Partner Company Revenue Stages


Initial Revenue Stage

·  Up to $1M in revenue

Expansion Stage

·  $1M to $5M in revenue

Traction Stage

·  $5M to $10M in revenue

High Traction Stage

·  $10M+ in revenue



Partner Companies

Stage

Category

Acquisition
Year

Primary
Ownership%

Carrying
Value

(in millions)


Cost

(in millions)









Aktana, Inc.

High Traction

Healthcare

2016

17.9%

$  4.7


$  11.7

Clutch Holdings, Inc.

High Traction

Digital Media

2013

41.2%

6.0


16.6

Flashtalking

High Traction

Digital Media

2018

10.1%

11.0


19.2

InfoBionic, Inc. 

Traction

Healthcare

2014

25.2%

-


22.0

Lumesis, Inc.

Traction

Financial Services

2012

43.6%

1.3


6.3

MediaMath, Inc.

High Traction

Digital Media

2009

13.4%

-


15.5

meQuilibrium

Traction

Healthcare

2015

32.7%

4.4


13.0

Moxe Health Corporation+

Expansion

Healthcare

2016

32.4%

3.4


5.8

Prognos Health, Inc.

High Traction

Healthcare

2011

28.7%

5.2


12.6

QuanticMind, Inc.

Traction

Digital Media

2015

24.2%

5.1


13.3

Sonobi, Inc.

Traction

Digital Media

2015

21.6%

8.0


13.4

Syapse, Inc.

High Traction

Healthcare

2014

20.1%

3.2


20.6

Trice Medical, Inc.

Expansion

Healthcare

2014

16.7%

2.4


10.2

WebLinc, Inc.

Traction

Digital Media

2014

38.5%

4.7


15.9

Zipnosis, Inc.

Expansion

Healthcare

2015

37.7%

3.4


10.0





TOTAL:

$  62.8


$206.1


+ Partner company progressed into higher revenue stage

 

CONFERENCE CALL AND WEBCAST DETAILS

Please call 10-15 minutes prior to the call to register.

Date:  Thursday, November 7, 2019

Time:  9:00 am ET

Webcast:  www.safeguard.com/events

Live Number:  833-236-5756 // (International) 647-689-4184

Replay Number:  800-585-8367 // (International) 416-621-4642

Access Code:  7078285

Speakers:  President and Chief Executive Officer, Brian J. Sisko; and Senior Vice President and Chief Financial Officer, Mark A. Herndon

Format:  Discussion of third quarter 2019 financial results followed by Q&A

Replay will be available through December 7, 2019 at 11:59 pm ET.  For more information please contact [email protected]

About Safeguard Scientifics
Historically, Safeguard Scientifics (NYSE:SFE) has provided capital and relevant expertise to fuel the growth of technology-driven businesses.  Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades.  For more information, please visit www.safeguard.com.

Forward-looking Statements
Except for the historical information and discussions contained herein, statements contained in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Our forward-looking statements are subject to risks and uncertainties.  Forward-looking statements include, but are not limited to, statements regarding Safeguard's intention to pay a special cash dividend, the amount and timing of the special cash dividend.  Safeguard's initiatives taken or contemplated to enhance and unlock value for all of its shareholders, Safeguard's efforts to execute on and implement its strategy to streamline its organizational structure, reduce its operating costs, pursue monetization opportunities for partner companies and maximize the return of value to its shareholders, Safeguard's ability to create, unlock, enhance and maximize shareholder value, the effect of Safeguard's management succession plan on driving increased organizational effectiveness and efficiencies, the ability of the management team to execute Safeguard's strategy, the availability of, the timing of, and the proceeds that may ultimately be derived from the monetization of partner companies, Safeguard's projections regarding the reduction in its ongoing operating expenses, Safeguard's projections regarding annualized operating expenses and expected severance expenses, monetization opportunities for partner company interests, and the amount of net proceeds from the monetization of partner company interests that will enable the return of value to Safeguard shareholders after satisfying working capital needs and the timing of such return of value.  Such forward-looking statements are not guarantees of future operational or financial performance and are based on current expectations that involve a number of uncertainties, risks and assumptions that are difficult to predict.  Therefore, actual outcomes and/or results may differ materially from those expressed or implied by such forward-looking statements.  The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the monetization of our partner companies for maximum value or at all and the return of value to our shareholders, our ability to successfully execute on our strategy to streamline our organizational structure and align our cost structure to increase shareholder value, whether our strategy will better position us to focus our resources on the highest-return opportunities and deliver enhanced shareholder value, the ongoing support of our existing partner companies, the fact that our partner companies may vary from period to period, challenges to achieving liquidity from our partner company holdings, fluctuations in the market prices of our publicly traded partner company holdings, if any, competition, our inability to obtain maximum value for our partner company holdings, our ability to attract and retain qualified employees, market valuations in sectors in which our partner companies operate, our inability to control our partner companies, our need to manage our assets to avoid registration under the Investment Company Act of 1940, risks, disruption, costs and uncertainty caused by or related to the actions of activist shareholders, including that if individuals are elected to our Board with a specific agenda, it may adversely affect our ability to effectively implement our business strategy and create value for our shareholders and perceived uncertainties as to our future direction as a result of potential changes to the composition of our Board may lead to the perception of a change in the direction of our business, instability or a lack of continuity that may adversely affect our business, and risks associated with our partner companies, including the fact that most of our partner companies have a limited operating history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which Safeguard's partner companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission.  Many of these factors are beyond the Company's ability to predict or control.  As a result of these and other factors, the Company's past operational and financial performance should not be relied on as an indication of future performance.  The Company does not assume any obligation to update any forward-looking statements or other information contained in this press release.

SAFEGUARD CONTACT:
John E. Shave III, IRC
Safeguard Investor Relations
(610) 975-4952
[email protected]

 

Safeguard Scientifics, Inc.
Condensed Consolidated
Balance Sheets (in thousands)



September 30, 2019


December 31, 2018

Assets

Cash, cash equivalents, restricted cash and marketable securities

 

 

$                      45,564


 

 

$                      46,158

Other current assets

2,764


2,669

Total current assets

48,328


48,827

Ownership interests in and advances to partner companies

79,645


95,585

Other assets

2,876


1,325

Total Assets

$                   130,849


$                   145,737

 

Liabilities and Equity

Other current liabilities

 

 

$                        3,708


 

 

$                        5,780

Credit facility - current

?


22,100

Credit facility repayment feature

?


5,060

Total current liabilities

3,708


32,940

Credit facility - non-current

?


43,014

Lease liability - non-current

2,476


?

Other long-term liabilities

1,728


2,804

Total equity

122,937


66,979

Total Liabilities and Equity

$                   130,849


$                   145,737

          

Safeguard Scientifics, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)



Three Months Ended
September 30,


Nine Months Ended
September 30,


2019


2018


2019


2018

 

Operating expenses

 

$                 2,262


 

$                 3,516


 

$                 7,922


 

$               14,253

Operating loss

(2,262)


(3,516)


(7,922)


(14,253)

Other income (loss), net

8,777


(1,078)


10,010


(4,965)

Interest, net

(5,572)


(2,592)


(12,153)


(7,240)

Equity income (loss), net

(3,440)


39,246


65,324


27,452

Net income (loss) before income taxes

(2,497)


32,060


55,259


994

Income tax benefit (expense)

?


?


?


?

Net income (loss)

$                (2,497)


$               32,060


$               55,259


$                    994

 

Net income (loss) per share:








Basic

$                  (0.12)


$                   1.56


$                   2.68


$                   0.05

Diluted

$                  (0.12)


$                   1.56


$                   2.68


$                   0.05

Weighted average shares used in computing income (loss)
per share:








Basic

20,657


20,561


20,623


20,535

Diluted

20,657


20,561


20,623


20,535

 

Safeguard Scientifics, Inc.
Partner Company Financial Data
(in thousands)

Additional Financial Information
To assist investors in understanding Safeguard and our 15 remaining partner companies as of September 30, 2019, we are providing additional financial information on our partner companies, including the aggregate cost and carrying value for all of our partner companies and other holdings. Carrying value of an equity method partner company represents the original acquisition cost and any follow-on funding, plus or minus our share of the earnings or losses of each company, reduced by any impairment charges. The carrying value and cost data reflect our percentage holdings in the partner companies and reflect both equity ownership interests in and advances to those partner companies.

 


September 30,
2019




Carrying
Value


Cost
(including
transaction
costs


Safeguard Carrying Value and Cost




 Equity method partner companies

$           51,759


$  171,322

Other partner companies

10,956


34,703

Other holdings

16,930


23,942


$           79,645


$ 229,967

 






 

Three Months Ended
September 30,


Nine Months Ended
September 30,


2019


2018



2019


2018

Corporate costs

$        1,923


$        2,205



$              5,964


$       7,960

Depreciation

?


51


808


207

Stock based compensation

248


243


934


853

Severance and retirement costs

91


1,017


216


3,816

Non-recurring items, principally professional fees

?


?



?


1,417

General and administrative costs

$        2,262


$        3,516



$              7,922


$     14,253


 

Non-GAAP Measures

In discussing financial results and guidance, the Company refers to the measure "corporate costs" which is not in accordance with Generally Accepted Accounting Principles (GAAP). We use this non-GAAP financial measure internally to make operating and strategic decisions, including evaluating our overall performance and as a factor in determining compensation for certain employees. We believe presenting this non-GAAP financial measure provides additional information to facilitate comparison of our historical operating costs and their trends, and provides additional transparency on how we evaluate our cost structure. We also believe presenting this measure allows investors to view our performance using the same measure that we use in evaluating our performance and trends.

 

SOURCE Safeguard Scientifics, Inc.


These press releases may also interest you

at 08:00
via IBN ? Torr Metals Inc. ("Torr" or the "Company") is very pleased to announce preliminary results that have identified near-surface high priority geophysical resistivity anomalies extending up to >1.5 kilometers (km) depth that are coincident...

at 07:55
Syra Health Corp. ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it has been selected by the City of Portland in...

at 07:53
Trading resumes in: Company: Equinox Gold Corp. TSX Symbol: EQX All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...

at 07:47
Today BDO Canada announced its newly created AI solution that will help solve critical challenges currently facing the financial services industry in Canada. Leveraging AI and machine learning, this technology offers tailor-made services in wealth...

at 07:45
Equifax® Workforce Solutions continues to help businesses transform the employee experience with the launch of Forms HQ, a new offering designed to help automate the delivery, completion, and tracking of essential employee forms, including those...

at 07:42
Noah Holdings Limited ("Noah" or the "Company") , a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for Mandarin-speaking high net worth...



News published on and distributed by: